Skip to content

Overview

The Dementia Consortium that partners between ARUK and 7 Industry Partners and 2 CROs has accelerated dementia target validation and drug discovery for the development of new treatments.

partner logos

1 Founding Charity providing access to the best Translational Research into Dementia worldwide

7 Pharmaceutical industry partners

2 Contract-research organisations

Over 80 Scientists currently collaborating across Industry and Academia

Target Applications from 125 academic research organisations across 25 Countries

12 Targets being explored in DC2

8 Targets explored In DC1

A 10m initiative with 6.4m income from Industry

Overview timeline

  • 1 Founding Charity providing access to the best Translational Research into Dementia worldwide

  • 7 Pharmaceutical industry Partners

    2 Contract-Research organisations

  • Over 80 Scientists currently collaborating across Industry and Academia

  • Target Applications from 125 Academic research organisations across 25 Countries

  • 12 Targets being explored in DC2

    8 targets explored in DC1

  • A 10m initiative with 6.5m income from Industry